311 A pharmacogenomic scoring system predicting median time-to-progression on sunitinib as first line treatment in patients with metastatic renal cell carcinoma

✍ Scribed by B. Beuselinck; A. Karadimou; B. Claes; D. Lambrechts; J. Berkers; R. Paridaens; P. Schöffski; Poppel H. Van; P. Wolter; A. Méjean; E. Lerut; A. Descazeaud; J. Berger; J.M. Tourani; V. Verkarre; B. Terris; V. Molinié; N. Rioux-Leclercq; J. Zucman-Rossi; S. Oudard

• Book ID: 119624243
• Publisher: Elsevier Science
• Year: 2012
• Tongue: English
• Weight: 56 KB
• Volume: 11
• Category: Article
• ISSN: 1569-9056
• DOI: 10.1016/s1569-9056(12)60308-x